Wang, Xiao-Fan
- Duke University · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #6,205
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$1.4M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#6,205
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Wang, Xiao-Fan as a PI. Multi-PI records show the full award amount for context.
- 5R01CA249726-04R01Contact PINGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanomaDuke University · Pharmacology (NIH department code)$494.5Kaward amount
- 5R01CA244564-04R01Contact PISynthetic lethality by targeting the core senescent mechanism in lung cancer.Duke University · Pharmacology (NIH department code)$478.4Kaward amount
- 5R01CA233205-05R01Contact PITargeting UHRF1 in combinational immunotherapyDuke University · Pharmacology (NIH department code)$461Kaward amount
Award organization
Organizations that administered FY2023 awards listing Wang, Xiao-Fan as a PI.
FY2023 award administered by Duke University (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardDuke University
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #2921
- 2006Entered Top 25% NationallyRanked #2921
- 2007$2M Cumulative Funding
- 2009$5M Cumulative Funding
- 2010R01 Grant Holder
- 2013$10M Cumulative Funding